Cost analysis of intra-arterial versus intra-venous delivery of bevacizumab for the treatment of recurrent glioblastoma multiforme.
Saved in:
| Title: | Cost analysis of intra-arterial versus intra-venous delivery of bevacizumab for the treatment of recurrent glioblastoma multiforme. |
|---|---|
| Authors: | Burkhardt, Jan-Karl1, Shin, Benjamin J.1, Schlaff, Cody D.1, Riina, Howard1, Boockvar, John A.1 jab2029@nyp.org |
| Source: | Journal of Experimental Therapeutics & Oncology. 2011, Vol. 9 Issue 3, p183-186. 4p. 1 Chart, 2 Graphs. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
